E Camilla Forsberg

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors
    E Camilla Forsberg
    Institute of Stem Cell Biology and Regenerative Medicine, Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Cell 126:415-26. 2006
  2. pmc Differential expression of novel potential regulators in hematopoietic stem cells
    E Camilla Forsberg
    Department of Pathology, Institute of Cancer and Stem Cell Biology and Medicine, Stanford University Medical School, Stanford, California, USA
    PLoS Genet 1:e28. 2005
  3. doi request reprint The adhesion molecule esam1 is a novel hematopoietic stem cell marker
    A G Lisa Ooi
    Institute of Stem Cell Biology and Regenerative Medicine, Department of Pathology, Stanford University School of Medicine, California, USA
    Stem Cells 27:653-61. 2009
  4. ncbi request reprint Hematopoietic stem cells: expression profiling and beyond
    E Camilla Forsberg
    Institute of Cancer and Stem Cell Biology and Medicine, Departments of Pathology and Developmental Biology, Stanford University Medical School, 279 Campus Drive, Stanford, CA 94305, USA
    Stem Cell Rev 2:23-30. 2006
  5. pmc Cholinergic activation of hematopoietic stem cells: role in tobacco-related disease?
    Edwin Chang
    Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
    Vasc Med 15:375-85. 2010
  6. pmc Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis
    Joanne L Attema
    Institute of Stem Cell Biology and Regenerative Medicine, Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 104:12371-6. 2007

Detail Information

Publications6

  1. ncbi request reprint New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors
    E Camilla Forsberg
    Institute of Stem Cell Biology and Regenerative Medicine, Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Cell 126:415-26. 2006
    ....
  2. pmc Differential expression of novel potential regulators in hematopoietic stem cells
    E Camilla Forsberg
    Department of Pathology, Institute of Cancer and Stem Cell Biology and Medicine, Stanford University Medical School, Stanford, California, USA
    PLoS Genet 1:e28. 2005
    ..In particular, our data suggest that cell-cell and cell-matrix interactions are major regulators of long-term HSC, and that HSC themselves play important roles in regulating their immediate microenvironment...
  3. doi request reprint The adhesion molecule esam1 is a novel hematopoietic stem cell marker
    A G Lisa Ooi
    Institute of Stem Cell Biology and Regenerative Medicine, Department of Pathology, Stanford University School of Medicine, California, USA
    Stem Cells 27:653-61. 2009
    ..These studies identify Esam1 as a novel, widely applicable HSC-selective marker and suggest that Esam1 may play roles in both HSC proliferation and lineage decisions...
  4. ncbi request reprint Hematopoietic stem cells: expression profiling and beyond
    E Camilla Forsberg
    Institute of Cancer and Stem Cell Biology and Medicine, Departments of Pathology and Developmental Biology, Stanford University Medical School, 279 Campus Drive, Stanford, CA 94305, USA
    Stem Cell Rev 2:23-30. 2006
    ....
  5. pmc Cholinergic activation of hematopoietic stem cells: role in tobacco-related disease?
    Edwin Chang
    Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
    Vasc Med 15:375-85. 2010
    ..In conclusion, the data suggest a new mechanism for the increased WBC associated with tobacco use. The effect of nicotine to activate hematopoiesis may contribute to tobacco-related diseases...
  6. pmc Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis
    Joanne L Attema
    Institute of Stem Cell Biology and Regenerative Medicine, Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Proc Natl Acad Sci U S A 104:12371-6. 2007
    ..Together, these data support a model in which epigenetic modifications serve as an important mechanism to control HSC multipotency...